| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |